Track the BetterLife Pharma Inc. share price and the full insider trade history of the company, a listed issuer based in Canada. Shares are listed on CA CA, under the supervision of SEDI. Operating in the Health Care sector, BetterLife Pharma Inc. has logged 26 insider filings. Market capitalisation: €30.8m. The latest transaction was filed on 10 July 2026 (50 - Grant of options). Among the most active insiders: Sangha, Steven. All data is free.
26
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
39Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
327,000 shares@ CA$0.0695.6% of flowCommon SharesTSXSEDI:4724251
Ideal exit: 21 Feb 2027 (T+270)
25 of 26 declarations
About BetterLife Pharma Inc.
BetterLife Pharma Inc. is a company focused on developing innovative therapeutic solutions in the healthcare and pharmaceutical sector. It is listed on the XTSE.